Work

Integrated genomic and metabolomic analysis reveals the anti-inflammatory potential of Bifidobacterium animalis subsp. lactis BGI-N3 in DSS-induced colitis

Year: 2026
Type: article
Abstract: Probiotics offer a promising therapeutic avenue for inflammatory bowel disease (IBD), yet their efficacy is highly strain-specific and mechanistically complex. To address this, this study integrated complete genome sequencing, in vitro assays, and in vivo metabolomics to elucidate the anti-inflammatory mechanisms of Bifidobacterium animalis subsp. lactis BGI-N3. Genomic analysis confirmed the presence of gene clusters associated with stress tolerance and immunomodulation. Functionally, BGI-N3 suppressed LPS-induced pro-inflammatory cytokines in monocytes and significantly alleviated DSS-induced colitis in mice by restoring mucosal architecture. Crucially, untargeted metabolomics demonstrated that BGI-N3 intervention restructured the gut metabolic landscape, specifically enriching anti-inflammatory metabolites, including ergocalciferol, vanillin, and dihomo-gamma-linolenic acid (DGLA). These metabolites correlated positively with IL-10 levels and negatively with pro-inflammatory markers. Collectively, these findings provided genomic validation and insights into metabolic changes associated with the protective effects of BGI-N3, highlighting its potential as a functional probiotic for alleviating intestinal inflammation.
Language: English
Subfield: Food Science
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236350387
FWCI:
Cites: 48
Cited by:
Related to: 10
Parts: 1